...
首页> 外文期刊>Pathology oncology research: POR >Comprehensive treatment based on intra-arterial chemotherapy for distal femur neoplasms
【24h】

Comprehensive treatment based on intra-arterial chemotherapy for distal femur neoplasms

机译:基于动脉内化疗的股骨远端肿瘤综合治疗

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

To investigate the clinical efficacy of intra-arterial chemotherapy by subcutaneous implantable delivery system (SIDS) in the treatment of distal femur neoplasm. From March 2002 to December 2009, 51 patients were treated with SIDS intra-femoral artery chemotherapy, followed by customized prosthetic reconstruction, including 45 patients of osteosarcoma and 6 malignant fibrous histiocytoma in distal femur. The average follow-up period was 64 months (ranging between 24 and 116 months) to track on the efficacy of chemotherapy, which shows that 96.1 % of patients got pain relief, 70.6 % of patients had significant radiological change, and 82.4 % of paitents with medium to severe pathological variation responded to the chemotherapy. Local recurrence happened in 4 cases, 3 cases are alive with disease, 4 cases died because of pulmonary metastases and other 40 patients are free of local recurrence or distant metastasis. SIDS intra-femur artery chemotherapy can improve clinical outcome of DFN, and provide effective method for treatment of DFN when combined with customized prosthetic reconstruction.
机译:探讨皮下植入输送系统(SIDS)进行动脉内化疗在股骨远端肿瘤治疗中的临床疗效。从2002年3月至2009年12月,对51例SIDS股内动脉化疗患者进行了治疗,随后进行了定制的假体重建,包括45例骨肉瘤患者和6例股骨远端恶性纤维组织细胞瘤。平均随访期为64个月(24个月至116个月),以追踪化学疗法的疗效,这表明96.1%的患者缓解了疼痛,70.6%的患者有显着的放射学改变以及82.4%的患者中度至重度病理变化对化疗有反应。发生局部复发4例,存活3例,因肺转移死亡4例,其余40例无局部复发或远处转移。 SIDS股骨内动脉化疗可改善DFN的临床效果,并结合定制的假体重建提供治疗DFN的有效方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号